N-Nitroso Palbociclib

N-Nitroso Palbociclib

N-Nitroso Palbociclib is an impurity present in Palbociclib, Palbociclib highly selective cyclin-dependent kinase 4/6 inhibitor, Palbociclib in combination with endocrine therapy is a valuable emerging option for patients with HR+/HER2− advanced or metastatic breast cancer.

Additional information on N-Nitroso Palbociclib

Catalogue No.

VE009744
CAS No.

N/A
Molecular Formula

C24H28N8O3
Molecular Weight

476.53 g/mol
Parent drug

Palbociclib
IUPAC Name

6-acetyl-8-cyclopentyl-5-methyl-2-((5-(4-nitrosopiperazin-1-yl)pyridin-2-yl)amino)pyrido[2, 3-d]pyrimidin-7(8H)-one
Synonyms

N/A
References

Serra, F., Lapidari, P., Quaquarini, E., Tagliaferri, B., Sottotetti, F., & Palumbo, R. (2019). Palbociclib in metastatic breast cancer: current evidence and real-life data. Drugs in Context, 8, 1–16. https://doi.org/10.7573/dic.212579
Status

In-stock

Other products related to palbociclib

[rfq_list]

Login first to add product to RFQ List

Request a quote

N-Nitroso Palbociclib

N-Nitroso Palbociclib
Catalogue No.

VE009744
CAS No.

N/A
Molecular Formula

C24H28N8O3
Molecular Weight

476.53 g/mol
Parent drug

Palbociclib
IUPAC Name

6-acetyl-8-cyclopentyl-5-methyl-2-((5-(4-nitrosopiperazin-1-yl)pyridin-2-yl)amino)pyrido[2, 3-d]pyrimidin-7(8H)-one
Synonyms

N/A
References

Serra, F., Lapidari, P., Quaquarini, E., Tagliaferri, B., Sottotetti, F., & Palumbo, R. (2019). Palbociclib in metastatic breast cancer: current evidence and real-life data. Drugs in Context, 8, 1–16. https://doi.org/10.7573/dic.212579
Status

In-stock
ListName

N-Nitroso Palbociclib
Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url
 
Hidden